期刊文献+

重症患者早期血清基质金属蛋白酶-9、可溶性P-选择素测定的临床意义 被引量:1

Clinical significance of the concentration of matrix metalloproteinases-9 and soluble P-selections in early critically ill patients
下载PDF
导出
摘要 目的探讨早期检测血清基质金属蛋白酶-9(MMP-9)、可溶性P-选择素(sP-选择素)预测重症患者脓毒症(Sepsis)发生的临床意义。方法根据脓毒症及全身炎症反应综合征(SIRS)诊断标准,将104例重症患者分成三组,即A组(Sepsis组)44例,B组(SIRS组)36例,C组(非SIRS组)24例。检测患者转入ICU后2h内血清MMP-9、sP-选择素浓度及临床指标。结果①A、B、C组患者MMP-9平均水平依次为(6.46±0.58)mg/L、(6.01±0.71)mg/L、(5.22±0.73)mg/L,组间比较差异均有统计学意义(P<0.01)。②A、B组患者血清sP-选择素水平(2.40±1.98)mg/L、(2.11±1.50)mg/L显著高于C组患者(1.25±0.82)mg/L,差异有统计学意义(P<0.01)。③对影响患者病情严重程度的危险因素进行多元有序Logistic回归显示,MMP-9指标进入回归方程(P<0.01)。④ROC曲线分析显示早期测定MMP-9水平对判定重症患者脓毒症发生与否的曲线下面积达0.780(P<0.01)。结论 MMP-9、sP-选择素参与重症患者全身炎症反应启动和脓毒症的发生,早期MMP-9水平测定对于脓毒症发生的识别、病情判断具有一定的临床价值。 Objective To study the expression of serum matrix metalloproteinase-9(MMP-9),soluble P-selections(sP-selections) and to predict the clinical significance in diagnosis of critically ills with sepsis.Methods 104 patients with critically ill were admitted in ICU were divided into group A(sepsis,n=44),group B(SIRS,n=36) and group C(non-SIRS,n=24).The MMP-9 and sP-selections in serum of patients were measured within 2h admission in ICU.Results The average level of MMP-9 in group A,B,C were respectively 6.46 ± 0.58 mg/L,6.01 ± 0.71 mg/L,5.22 ± 0.73 mg/L and there were significantly different(P0.01).The average level of sP-selections in group A,B(2.40±1.98mg/L,2.11±1.50mg/L) was significantly higher than that in group C(1.25±0.82mg/L)(P0.01).Ordered multiple logistic regression on disease severity showed that MMP-9 indicator was into the regression equation(P0.01).ROC analysis showed that early MMP-9 levels of patients that area under the curve which was 0.780(P0.01).Conclusion MMP-9 and sP-selections may significantly impact on the pathological process of systemic inflammatory response syndrome and sepsis.The early measurement of MMP-9 is helpful in the identification of sepsis and to determine disease severity of critically ills.
出处 《宁夏医学杂志》 CAS 2011年第10期914-916,I0001,共4页 Ningxia Medical Journal
关键词 基质金属蛋白酶-9 可溶性P-选择素 脓毒症 全身炎症反应综合征 Matrix metalloproteinases-9 Soluble P-selection Sepsis Systemic inflammatory response syndrome
  • 相关文献

参考文献8

  • 1Koryza J,Pesek M,Puzman P,et al.Progelatinase Bmatrix metalloproteinase-9 proenzyme as a marker of pleural inflammation[J].Exp Lung Res,2004,30(4):297-309.
  • 2Levy MM,Fink MP,Marshall JC,et al.2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference[J].Crit Care Med,2003,31(4):1250-1256.
  • 3Knaus WA,Draper EA,Wanger DP,et al.APACHEⅡ:a severity of classification system[J].Critical Care Med,1985,13(40):818-829.
  • 4Vincent JL,Moreno R,Takala J,et al.The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfuntion/failure[J].Intensive Care Med,1996,22:707-710.
  • 5Dellinger RP,Carlet JM,Masur H,et al.Surviving sepsis campaign guidelines formanagement of severe sepsis and septic shock[J].Crit Care Med,2004,32(3):858-873.
  • 6丁欢,马希刚,马玉杰,曹相原,杨晓军,王晓麒.脓毒症患者血浆抗凝血酶Ⅲ及D-二聚体与SOFA评分的相关性研究[J].中国实用内科杂志,2008,28(2):113-115. 被引量:16
  • 7Giovanni Davi MD,Carlo Patrono MD.Platelet activation and atherothrombosis[J].N Engl J Med,2007,357:2482-2494.
  • 8Jean-Francois Theoret,Wissam Chahrour,Daniel Yacoub,et al.Recom-binant P-selectin glycoprotein-ligand-1 delays thrombin-induced platelet aggregation:a new role for P-selectin in early aggregation[J].Br J Pharmacol,2006,148(3):299-305.

二级参考文献10

  • 1Kinasewitz GT, Yan SB, Basson B,et al. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ J ]. Crit Care, 2004,8 ( 2 ) : R82 - R90.
  • 2Arts DG,de Keizer NF,Vroom MB,et al. Reliability and accuracy of sequential organ failure assessment ( SOFA ) scoring [ J ]. Crit Care Med,2005,33 ( 9 ) : 1988 - 1993.
  • 3Mitchell M, Mitchell P, John C ,et al. 2001 SCCM/ESICM/ACCP/ ATS/SIS international sepsis definitions conference [ J ]. Int Care Med ,2003,29:530 - 538.
  • 4Vincent JL, de Mendonca A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units:results of a muhicenter, prospective study [ J ]. Crit Care Med, 1998,26( 11 ) : 1793 - 1880.
  • 5Amaral A, Opal SM, Vincent JL. Coagulation in sepsis [ J ]. Int Care Med,2004 ,30 (6) : 1032 - 1040.
  • 6Cando S,Nanzaki S,Sasaki S,et al. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock [ J ]. Crit Care Med, 1998,26:2005 - 2009.
  • 7Moreno R, Vincent JL, Matos R, et al. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care:results of a prospective, muhicentre study [ J ]. Int Care Med, 1999,25 (7) :686 -696.
  • 8Maria MA, Pena JM, Fernandez A, et al. Time course and prognostic significant of hemostatic changes in sepsis: relation to tumor necrosis factor-α [ J ]. Crit Care Med, 1999,27 : 1303 - 1308.
  • 9Minnema MC, Chang AC, Jansen PM, et al. Recombinant human antithrombin Ⅲ improves survival and attenuates inflammatory responses in baboons lethally challenged with Eschcrichia coli [ J ]. Blood,2000,95 (4) :1117 - 1123.
  • 10Warren BL, Eid A,Singer P, et al. High dose antithrombin Ⅲ in severe sepsis: a randomized controlled trial [ J ]. JAMA, 2001 , 286 : 1869 - 1878.

共引文献15

同被引文献8

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部